Skip To Main Content
April K.S on Muck Rack

April K.S

As seen in: Acta Neuropathologica Communications, Journal of Immunotherapy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to April K.S’s profile

Articles by April K.S

A comprehensive, multi-center, immunogenomic analysis of melanoma brain metastases - Acta Neuropathologica Communications

|
By Van Swearingen, Amanda D, April K.S, Lucy Boyce
| Acta Neuropathologica Communications
A previously published dataset (available from EGA: EGAD00001005046) from MDACC based on 82 patients was obtained through a data transfer agreement. It includes RNAseq on surgically resected, FFPE MBM (88 tumor samples (m) from 74 patients (n)) and surgically resected ECM from an overlapping set of patients (hereafter “MDACC dataset”, Fig. 1) [18].
Open in Who Shared Issue with article?

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study

|
By April K.S, Thomas R. Jeffry
| gla.ac.uk
Hamid, O. et al. (2023) Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study. Journal for ImmunoTherapy of Cancer, 11(6), e006747. (doi: 10.1136/jitc-2023-006747) (PMID:37286303) (PMCID:PMC10254987) Text 300986.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. 3MB Abstract Background: Immune checkpoint inhibitors have significantly improved outcomes in first line cutaneous melanoma.
Open in Who Shared Issue with article?

Identification of a Germline Pyrin Variant in a Metastatic... : Journal of Immunotherapy

|
By April K.S
| Journal of Immunotherapy Verified
As the utilization of checkpoint inhibitor immunotherapy continues to expand in oncology, the diagnosis and management of immune-related adverse events (irAEs) has become an important health care issue.1,2 To improve our ability to manage and predict the development of these irAEs, a more sophisticated understanding of the underlying molecular pathogenesis of these conditions is necessary.3 Given the diversity of the clinical presentations of the irAEs, studying these conditions can be...
Open in Who Shared Issue with article?
Show More